The Relation Between Fibroblast Growth Factor 21 and Insulin Resistance in hyperlipidemia Patients

Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients

Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients

Serum Fibroblast Growth Factor 23 as an Early Biomarker for Detection of Renal Osteodystrophy and Progression of Chronic Kidney Disease in Children

OBESITY AND TYPE 3 DIABETES: NUTRITIONAL APPROACHES AND THERAPEUTIC IMPLICATION

Serum Fibroblast Growth Factor 21 and Its Relation to Diabetic Kidney (DKD) Disease and Cardiovascular Risk (ASCVD) in Type 2 Diabetic Patients

Metabolic Syndrome and the Risk of Kidney Diseases: the Impact of Lifestyle Modification

Fibroblast growth factor-21 is a novel linkage between metabolic parameters, cardiovascular risk, and nephropathy in prediabetes

The relation between fibroblast growth factor 23 level and anemia in chronic kidney disease patients.

Serum levels of fibroblast growth factor-21 (FGF 21) in coronary heart disease